144 related articles for article (PubMed ID: 20036561)
1. Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.
Jozwiak K; Woo AY; Tanga MJ; Toll L; Jimenez L; Kozocas JA; Plazinska A; Xiao RP; Wainer IW
Bioorg Med Chem; 2010 Jan; 18(2):728-36. PubMed ID: 20036561
[TBL] [Abstract][Full Text] [Related]
2. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
[TBL] [Abstract][Full Text] [Related]
3. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
4. Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.
Jozwiak K; Plazinska A; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Chirality; 2011; 23 Suppl 1(Suppl 1):E1-6. PubMed ID: 21618615
[TBL] [Abstract][Full Text] [Related]
5. Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.
Plazinska A; Pajak K; Rutkowska E; Jimenez L; Kozocas J; Koolpe G; Tanga M; Toll L; Wainer IW; Jozwiak K
Bioorg Med Chem; 2014 Jan; 22(1):234-46. PubMed ID: 24326276
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.
Beigi F; Bertucci C; Zhu W; Chakir K; Wainer IW; Xiao RP; Abernethy DR
Chirality; 2006 Nov; 18(10):822-7. PubMed ID: 16917835
[TBL] [Abstract][Full Text] [Related]
7. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
Reinartz MT; Kälble S; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.
Toll L; Pajak K; Plazinska A; Jozwiak K; Jimenez L; Kozocas JA; Tanga MJ; Bupp JE; Wainer IW
Mol Pharmacol; 2012 Jun; 81(6):846-54. PubMed ID: 22434858
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
[TBL] [Abstract][Full Text] [Related]
10. Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.
Woo AY; Wang TB; Zeng X; Zhu W; Abernethy DR; Wainer IW; Xiao RP
Mol Pharmacol; 2009 Jan; 75(1):158-65. PubMed ID: 18838481
[TBL] [Abstract][Full Text] [Related]
11. The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.
Jozwiak K; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Biochem Pharmacol; 2010 Jun; 79(11):1610-5. PubMed ID: 20144591
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective binding of agonists to the β
Plazinska A; Plazinski W
Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
[TBL] [Abstract][Full Text] [Related]
13. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
Plazinska A; Plazinski W; Jozwiak K
J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
15. {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.
Toll L; Jimenez L; Waleh N; Jozwiak K; Woo AY; Xiao RP; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2011 Feb; 336(2):524-32. PubMed ID: 21071556
[TBL] [Abstract][Full Text] [Related]
16. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
17. Beta-agonist-induced constitutive beta(2)-adrenergic receptor activity in bovine tracheal smooth muscle.
de Vries B; Meurs H; Roffel AF; Elzinga CR; Hoiting BH; de Vries MM; Zaagsma J
Br J Pharmacol; 2000 Nov; 131(5):915-20. PubMed ID: 11053211
[TBL] [Abstract][Full Text] [Related]
18. CoMFA analysis of the human beta(1)-adrenoceptor binding affinity of a series of phenoxypropanolamines.
Louis SN; Rezmann-Vitti LA; Nero TL; Iakovidis D; Jackman GP; Louis WJ
Eur J Med Chem; 2002 Feb; 37(2):111-25. PubMed ID: 11858844
[TBL] [Abstract][Full Text] [Related]
19. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
[TBL] [Abstract][Full Text] [Related]
20. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
Plazinska A; Plazinski W; Jozwiak K
Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
